Hypertrophic pulmonary osteoarthropathy associated with disease progression in renal cell carcinoma

Journal of the Chinese Medical Association

Volumn 66, Issue 1, 2003, Pages 63-66

  Chen, Yen Cheng ^a,b   Tiu, Chui Mei ^a,b   Bai, Li Yuan ^a,b   Liu, Jin Hwang ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Clubbing; Hypertrophic osteoarthropathy; Renal cell carcinoma

Indexed keywords

CYTOKINE; NONSTEROID ANTIINFLAMMATORY AGENT; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; SIGNAL PEPTIDE; VASCULOTROPIN A;

ADULT; ANAMNESIS; ARTHRALGIA; ARTHRITIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; BRAIN METASTASIS; CASE REPORT; CLUBBING FINGERS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; KIDNEY CARCINOMA; LUNG BIOPSY; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MEDICAL DECISION MAKING; MEDICAL LITERATURE; NEPHRECTOMY; OSTEOARTHROPATHY; PARANEOPLASTIC SYNDROME; PATHOGENESIS; PATIENT ATTITUDE; PERIOSTEUM; PROGNOSIS; REVIEW; THORAX RADIOGRAPHY; ARTICLE; KIDNEY TUMOR; MIDDLE AGED; PHYSIOLOGY;

CARCINOMA, RENAL CELL; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; OSTEOARTHROPATHY, SECONDARY HYPERTROPHIC; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0038657956     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Firooznia H, Seliger G, Geniseser NB, Barasch E. Hypertrophic pulmonary osteoarthropathy in pulmonary metastases. Radiology 1975;115:269-74.
2. Skarin A. Hypertrophic osteoarthropathy. J Clin Oncol 1997;15:2759-60.
3. Matucci-Cerinic M. First international workshop on hypertrophic osteoarthropathy. Clin Exp Reumatol 1992;10(Suppl 7): 1-76.
4. Wilmshurst PT, Mills KR, Drabu YJ. Renal carcinoma with thrombocytopenia, clubbing, and hypertrophic osteoarthropathy. Brit Med J 1979;1:381.
5. Golimbu C, Marchetta P, Firooznia H, Rafii M. Hypertrophic osteoarthropathy in metastatic renal cell carcinoma. Urology 1983;22:669-72.
6. Goldstraw P, Walbaum PR. Hypertrophic pulmonary osteoarthropathy and its occurrence with pulmonary metastases from renal carcinoma. Thorax 1976;31:205-11.
7. Allison NL, Store RM, Rai R, Roy RH, Dubb JW. Pulmonary osteoarthropathy preceding evidence of metastases from hypernephroma. Lancet 1981;1:950.
8. Hirakata Y, Kitamura S. Elevated serum transforming growth factor beta 1 level in primary lung cancer patients with finger clubbing. Eur J Clin Invest 1996;26:820-3.
9. Silveira LH, Martinez-Lavin M, Pineda C, Fonseca MC, Navarro C, Nava A. Vascular endothelial growth factor and hypertrophic osteoarthropathy. Clin Exp Rheumatol 2000;18: 57-62.
10. Silveri F, De Angelis R, Argentati F, Brecciaroli D, Muti S, Cervini C. Hypertrophic osteoarthropathy: endothelium and platelet function. Clin Rheumatol 1996;15:435-9.
11. Martinez-Lavin M. Hypertrophic osteoarthropathy. Curr Opin Rheumatol 1997;9:83-6.
12. Dickinson CJ. The etiology of clubbing and hypertrophic osteoarthropathy. Eur J Clin Invest 1993;23:330-8.
13. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999;79: 1283-316.
14. Motzer RJ, Mazumdar M, Bacik J, Russo P, Berg WJ, Metz EM. Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma. J Clin Oncol 2000;18:1928-35.
15. Chouaib S, Asselin-Paturel C, Mami-Chouaib F, Caignard A, Blay JY. The host-tumor immune conflict; from immunosuppression to resistance and destruction. Immunol Today 1997;18:493-7.
16. Onishi T, Ohishi Y, Imagawa K, Ohmoto Y, Murata K. An assessment of the immunological environment based on intratumoral cytokine production in renal cell carcinoma. BJU Int 1999;83:488-92.